Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
Mengxia Liang, Yiwen Liu, Zheyuan Zhang, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 989-1003
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Chun Ye, Xiao Liu, Zilun Liu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 25
Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer
Bowen Li, Zixian Wei, Zhiyue Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 220, pp. 125-138
Open Access | Times Cited: 20
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway
Jianwei Zhang, Dan Zhang, Haisen Yin, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 29
NOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers
Yujie Zhou, Songyan Yu, Wenyong Zhang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14511-14511
Open Access | Times Cited: 25
Fusobacterium nucleatum carcinogenesis and drug delivery interventions
Zhenzhen Chen, Leaf Huang
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115319-115319
Closed Access | Times Cited: 10
Periodontal pathogens and cancer development
Yuxi Zhou, Joerg Meyle, Sabine Groeger
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 112-149
Open Access | Times Cited: 9
Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights
Linda Galasso, Fabrizio Termite, Irene Mignini, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 368-368
Open Access | Times Cited: 1
Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer
Na Wang, Si Wu, Lanxiang Huang, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics
Beena Briget Kuriakose, Ahmed Hussein Zwamel, Ayad Abdulrazzaq Mutar, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 1, pp. 27-40
Closed Access | Times Cited: 1
The role of oral microbiota in cancer
Zhou Lan, Weijia Liu, Hao Cui, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 20
Fusobacterium nucleatum: a novel immune modulator in breast cancer?
Alexa Little, Mark Tangney, Michael M. Tunney, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 18
Porphyromonas gingivalis promotes malignancy and chemo-resistance via GSK3β-mediated mitochondrial oxidative phosphorylation in human esophageal squamous cell carcinoma
Yiwen Liu, Fuyou Zhou, Haijun Yang, et al.
Translational Oncology (2023) Vol. 32, pp. 101656-101656
Open Access | Times Cited: 13
Periodontitis and progression of gastrointestinal cancer: current knowledge and future perspective
Kamyar Nasiri, Masoud Amiri Moghaddam, Enas Abdalla Etajuri, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 10, pp. 2801-2811
Closed Access | Times Cited: 12
The role of microbiota in esophageal squamous cell carcinoma: A review of the literature
Hsueh‐Chien Chiang, Michael W. Hughes, Wei‐Lun Chang
Thoracic Cancer (2023) Vol. 14, Iss. 28, pp. 2821-2829
Open Access | Times Cited: 12
Oral microbiota: the overlooked catalyst in cancer initiation and progression
Xinlin Wang, Xin He, Bin Zhong
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Interactions between the tumor microbiota and breast cancer
Hua Guo
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Activation of the tumor cell-intrinsic STING pathway induced by Fusobacterium nucleatum is associated with poor prognosis in esophageal cancer patients
Shotaro Nakajima, Katsuharu Saito, Satoshi Fukai, et al.
Esophagus (2025)
Closed Access
Radiotherapy modulates autophagy to reshape the tumor immune microenvironment to enhance anti-tumor immunity in esophageal cancer
Suna Zhou, Haihua Yang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189302-189302
Open Access
Intestinal and esophageal microbiota in esophageal cancer development and treatment
Yuta Baba, Kohei Tajima, Kiyoshi Yoshimura
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Modulation of myeloid-derived suppressor cell functions by oral inflammatory diseases and important oral pathogens
Fernando García-Arévalo, Ana Gabriela Leija-Montoya, Javier González-Ramírez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
From microbes to medicine: harnessing the power of the microbiome in esophageal cancer
Xiaoyan Liu, Bang Li, Liping Liang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer
Tian Wang, Yushu Hu, Silvia Dusi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Emerging avenues linking myeloid-derived suppressor cells to periodontal disease
Ana Gabriela Leija-Montoya, Javier González-Ramírez, Idanya Serafín-Higuera, et al.
International review of cell and molecular biology (2023), pp. 165-189
Closed Access | Times Cited: 4
Persistent NLRP3 inflammasome activation is associated with delayed immunosuppression in septic patients
Rémy Coudereau, Maxime Bodinier, Anne‐Claire Lukaszewicz, et al.
Journal of Leukocyte Biology (2023) Vol. 115, Iss. 4, pp. 706-713
Closed Access | Times Cited: 4
Impact of Fusobacterium nucleatum in the treatment of cancer, including radiotherapy and its future potential in esophageal cancer
Manato Ohsawa, Hiromi Nishi, Manabu Emi, et al.
Journal of Radiation Research (2024) Vol. 65, Iss. Supplement_1, pp. i126-i134
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top